Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terpin SCHEMBL19192 | 1.00 | TRPA1 (0.40) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL9536260 | 1.00 | TRPA1 (0.40) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL29867 | 0.98 | TRPA1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL2487459 | 0.98 | TRPA1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL5177695 | 0.95 | TRPA1 (0.38) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL12506199 | 0.89 | PTGS1 (0.36) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| Terpin SCHEMBL5823396 | 0.89 | PTGS1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| SCHEMBL12384745 | 0.82 | ALDH1A1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| SCHEMBL13900364 | 0.82 | ALDH1A1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 | |
| SCHEMBL10013221 | 0.82 | ALDH1A1 (0.39) | TRPA1ALDH1A1TDP1ESR2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084046-B2 | Incorporation of certain isoprenoid compounds into catamenial tampon to reduce or eliminate pathogenic microorganisms and menstrually occurring Toxic Shock Syndrome | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-12-27 | — | — | US | claimed |
| US-7294651-B2 | Inhibition of exoprotein production using isoprenoid compositions | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2007-11-13 | — | — | US | claimed |
| US-6911480-B2 | Methods for the inhibition of exoprotein production from Gram positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2005-06-28 | — | — | US | claimed |
| US-20050070604-A1 | Inhibition of exoprotein production using isoprenoid compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2005-03-31 | — | — | US | claimed |
| EP-1432458-A1 | INHIBITION OF EXOPROTEINS USING ISOPRENOIDS | KIMBERLY-CLARK CORPORATION (US) | 2004-06-30 | — | — | EP | claimed |
| US-20030165559-A1 | Non-absorbent articles containing additives | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-09-04 | — | — | US | claimed |
| US-20030161865-A1 | Non-absorbent articles containing additives | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-28 | — | — | US | claimed |
| US-20030158156-A1 | Methods for inhibiting the production of TSST-1 | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-20030158529-A1 | Absorbent articles containing additives | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-20030157148-A1 | Methods for inhibiting the production of TSST-1 | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-20030157149-A1 | Menstrual tampons comprising cerulenin, triclosan, or hexachlorophene to inhibit production of toxic shock syndrome toxins by gram-positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-21 | — | — | US | claimed |
| US-20030153629-A1 | Methods for the inhibition of exoprotein production from Gram positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-08-14 | — | — | US | claimed |
| US-6596290-B2 | Disposable product containing terpene; suppressing production of exotoxins by Gram positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-22 | — | — | US | claimed |
| US-20030105439-A1 | Inhibition of exoprotein production in absorbent articles using isoprenoids | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-06-05 | — | — | US | claimed |
| US-20030096877-A1 | Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-05-22 | — | — | US | claimed |
| WO-2003028777-A1 | INHIBITION OF EXOPROTEINS USING ISOPRENOIDS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-04-10 | — | — | WO | claimed |
| US-6534548-B1 | Vaginal cleansers and douches; inhibit production of exotoxins from Grampositive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-03-18 | — | — | US | claimed |
| US-10590152-B2 | Pinene-based flame retardant compounds | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2020-03-17 | — | — | US | disclosed |
| US-4831163-A | REACTING TERPIN HYDRATE OR TERPINEOL WITH PHOSPHORIC ACID; DISTILLATION | UNION CAMP CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0300117-A2 | Method of preparing cineoles | Union Camp Corporation (US) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030153629-A1 | Methods for the inhibition of exoprotein production from Gram positive bacteria | MRPL21, ENGASE, FNTB | TRPA1 4854/4885ALDH1A1 4820/4885TDP1 4407/4885 |
| US-20030161865-A1 | Non-absorbent articles containing additives | TST, TMT1A, MPST | TRPA1 781/4885ALDH1A1 2270/4885TDP1 1605/4885 |
| US-20030158156-A1 | Methods for inhibiting the production of TSST-1 | TST, TSSK1B, DNTT | TRPA1 4245/4885ALDH1A1 3495/4885TDP1 1529/4885 |
| US-20030165559-A1 | Non-absorbent articles containing additives | CNOT1, DCUN1D1, CNDP2 | TRPA1 520/4885ALDH1A1 3289/4885TDP1 1263/4885 |
| US-20030096877-A1 | Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions | FNTA, FNTB, GGPS1 | TRPA1 4579/4885ALDH1A1 4719/4885TDP1 4445/4885 |
| US-20050070604-A1 | Inhibition of exoprotein production using isoprenoid compositions | EXOC1, EXOC4, EXOC3 | TRPA1 4828/4885ALDH1A1 4800/4885TDP1 4192/4885 |
| US-20030157148-A1 | Methods for inhibiting the production of TSST-1 | TST, TMT1A, MPST | TRPA1 3097/4885ALDH1A1 3534/4885TDP1 1501/4885 |
| US-20030157149-A1 | Menstrual tampons comprising cerulenin, triclosan, or hexachlorophene to inhibit production of toxic shock syndrome toxins by gram-positive bacteria | TPSAB1, TPT1, TST | TRPA1 134/4885ALDH1A1 3909/4885TDP1 1758/4885 |
| US-10590152-B2 | Pinene-based flame retardant compounds | PFAS, PNN, PFN1 | TRPA1 555/4885ALDH1A1 2048/4885TDP1 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.